Fluorescence-expressing viruses allow rapid identification and separation of rare tumor cells in spiked samples of human whole blood

Surgery

Volumn 146, Issue 3, 2009, Pages 498-505

  Fong, Sandra M B ^a   Lee, Melissa K ^a   Adusumilli, Prasad S ^a   Kelly, Kaitlyn J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN;

ARTICLE; BLOOD SAMPLING; CANCER CELL CULTURE; CANCER THERAPY; CELL STRAIN MCF 7; COLORECTAL CANCER; CONTROLLED STUDY; DISSEMINATED CANCER; FLOW CYTOMETRY; FLUORESCENCE; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE MICROSCOPY; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; NONHUMAN; PREDICTION; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA; TUMOR CELL; VIRUS INFECTION; VIRUS MORPHOLOGY; VIRUS REPLICATION;

CELL LINE, TUMOR; CELL SEPARATION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GREEN FLUORESCENT PROTEINS; HERPESVIRUS 1, HUMAN; HUMANS; MICROSCOPY, FLUORESCENCE; NEOPLASTIC CELLS, CIRCULATING; RECOMBINANT PROTEINS;

EID: 68949221583     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2008.12.007     Document Type: Article

References (38)

1. Viadana E., Bross I.D.J., and Pickren J.W. Cascade spread of bloodborne metastases in solid and non-solid cancers of humans. In: Weiss L., and Gilbert H.A. (Eds). Pulmonary Metastasis (1978), Boston, GK Hall 142
2. Elshimali Y.I., and Grody W.W. The clinical significance of circulating tumor cells in the peripheral blood. Diagn Mol Pathol 15 (2006) 187-194
3. Paterlini-Brechot P., and Benali N.L. Circulating tumor cells (CTC) detection: clinical impact and future directions. Cancer Lett 253 (2007) 180-204
4. Jacob K., Sollier C., and Jabado N. Circulating tumor cells: detection, molecular profiling and future prospects. Expert Rev Proteomics 4 (2007) 741-756
5. Vona G., Sabile A., Louha M., Sitruk V., Romana S., Schutze K., et al. Isolation by size of epithelial tumor cells: a new method for the immunomorphological and molecular characterization of circulatingtumor cells. Am J Pathol 156 (2000) 57-63
6. Smirnov D.A., Zweitzig D.R., Foulk B.W., Miller M.C., Doyle G.V., Pienta K.J., et al. Global gene expression profiling of circulating tumor cells. Cancer Res 65 (2005) 4993-4997
7. Mao X., Shaw G., James S.Y., Purkis P., Kudahetti S.C., Tsigani T., et al. Detection of TMPRSS2:ERG fusion gene in circulating prostate cancer cells. Asian J Androl 10 (2008) 467-473
8. Nagrath S., Sequist L.V., Maheswaran S., Bell D.W., Irimia D., Ulkus L., et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 450 (2007) 1235-1239
9. Hawkins L.K., Lemoine N.R., and Kirn D. Oncolytic biotherapy: a novel therapeutic platform. Lancet Oncol 3 (2002) 17-26
10. Dock G. Rabies virus vaccination in a patient with cervical carcinoma. Am J Med Sci 127 (1904) 563
11. Smith R.R., Huebner R.J., Rowe W.P., Schatten W.E., and Thomas L.B. Studies on the use of viruses in the treatment of carcinoma of the cervix. Cancer 9 (1956) 1211-1218
12. Southam C.M., and Moore A.E. Clinical studies of viruses as antineoplastic agents, with particular reference to Egypt 101 virus. Cancer 5 (1952) 1025-1034
13. Hansen R.M., and Libnoch J.A. Remission of chronic lymphocytic leukemia after smallpox vaccination. Arch Intern Med 138 (1978) 1137-1138
14. Markert J.M., Medlock M.D., Rabkin S.D., Gillespie G.Y., Todo T., Hunter W.D., et al. Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial. Gene Ther 7 (2000) 867-874
15. Kemeny N., Brown K., Covey A., Kim T., Bhargava A., Brody L.A., et al. Phase I, open-label, dose-escalating study of a genetically engineered herpes simplex virus, NV1020, in subjects with metastatic colorectal carcinoma to the liver. Hum Gene Ther 17 (2006) 1214-1224
16. Mansour J.C., and Schwarz R.E. Molecular mechanisms for individualized cancer care. J Am Coll Surg 207 (2008) 250-258
17. Tewes M., Aktas B., Welt A., Mueller S., Hauch S., Kimmig R., et al. Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies. Breast Cancer Res Treat (2008) In press
18. Magne N., Chargari C., Deutsch E., Castadot P., Ghalibafian M., Bourhis J., et al. Molecular profiling of uterine cervix carcinoma: an overview with a special focus on rationally designed target-based anticancer agents. Cancer Metastasis Rev 27 (2008) 737-750
19. Wulfing P., Borchard J., Buerger H., Heidl S., Zanker K.S., Kiesel L., et al. HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients. Clin Cancer Res 12 (2006) 1715-1720
20. Wong R., Joe J., Kim S., Shah J., Horsburg B., and Fong Y. Oncolytic herpesvirus effectively treats murine squamous cell carcinoma and spreads by natural lymphatics to treat sites of lymphatic metastases. Hum Gene Ther 13 (2002) 1213-1223
21. Woo Y., Adusumilli P.S., and Fong Y. Advances in oncolytic viral therapy. Curr Opin Investig Drugs 7 (2006) 549-559
22. Bennett J.J., Delman K.A., Burt B.M., Mariotti A., Malhotra S., Zager J., et al. Comparison of safety, delivery, and efficacy of two oncolytic herpes viruses (G207 and NV1020) for peritoneal cancer. Cancer Gene Ther 9 (2002) 935-945
23. Bennett J.J., Adusumilli P., Petrowsky H., Burt B.M., Roberts G., Delman K.A., et al. Up-regulation of GADD34 mediates the synergistic anticancer activity of mitomycin C and a gamma134.5 deleted oncolytic herpes virus (G207). FASEB J 18 (2004) 1001-1003
24. Stanziale S.F., Stiles B.M., Bhargava A., Kerns S.A., Kalakonda N., and Fong Y. Oncolytic herpes simplex virus-1 mutant expressing green fluorescent protein can detect and treat peritoneal cancer. Hum Gene Ther 15 (2004) 609-618
25. Stiles B., Adusumilli P., Bhargava A., Stanziale S., Kim T., Chan M., et al. Minimally invasive localization of oncolytic herpes simplex viral therapy of micrometastatic pleural cancer. Cancer Gene Ther 13 (2006) 53-64
26. Adusumilli P.S., Eisenberg D.P., Chun Y.S., Ryu K.W., Ben-Porat L., Hendershott K.J., et al. Virally directed fluorescent imaging improves diagnostic sensitivity in the detection of minimal residual disease after potentially curative cytoreductive surgery. J Gastrointest Surg 9 (2005) 1138-1147
27. Adusumilli P.S., Stiles B.M., Chan M.K., Eisenberg D.P., Yu Z., Stanziale S.F., et al. Real-time diagnostic imaging of tumors and metastases by use of a replication-competent herpes vector to facilitate minimally-invasive oncological surgery. FASEB J 20 (2006) 726-728
28. Flehinger B.J., Melamed M.R., Zaman M.B., Heelan R.T., Perchick W.B., and Martini N. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Memorial Sloan-Kettering study. Am Rev Respir Dis 130 (1984) 555-560
29. Thunnissen F.B. Sputum examination for early detection of lung cancer. J Clin Pathol 56 (2003) 805-810
30. Trumper L., Menges M., Daus H., Kohler D., Reinhard J.O., Sackmann M., et al. Low sensitivity of the ki-ras polymerase chain reaction for diagnosing pancreatic cancer from pancreatic juice and bile: a multicenter prospective trial. J Clin Oncol 20 (2002) 4331-4337
31. Gervasoni A., Monasterio Munoz R.M., Wengler G.S., Rizzi A., Zaniboni A., and Parolini O. Molecular signature detection of circulating tumor cells using a panel of selected genes. Cancer Lett 263 (2008) 267-279
32. Went P.T., Lugli A., Meier S., Bundi M., Mirlacher M., Sauter G., et al. Frequent EpCam protein expression in human carcinomas. Hum Pathol 35 (2004) 122-128
33. Fehm T., Sagalowsky A., Clifford E., Beitsch P., Saboorian H., Euhus D., et al. Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. Clin Cancer Res 8 (2002) 2073-2084
34. Willipinski-Stapelfeldt B., Riethdorf S., Assmann V., Woelfle U., Rau T., Sauter G., et al. Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells. Clin Cancer Res 11 (2005) 8006-8014
35. Goeminne J.C., Guillaume T., and Symann M. Pitfalls in the detection of disseminated non-hematological tumor cells. Ann Oncol 11 (2000) 785-792
36. Adusumilli PS, Chun YS, Mullerad M, Chan M, Yu Z, Ben-Porat L, et al. Fluorescence assisted cytologic testing (FACT): ex-vivo viral method for enhancing detection of rare cancer cells in body fluids. Personal communication.
37. Sabile A., Louha M., Bonte E., Poussin K., Vona G., Mejean A., et al. Efficiency of Ber-EP4 antibody for isolating circulating epithelial tumor cells before RT-PCR detection. Am J Clin Pathol 112 (1999) 171-178
38. Stillwagon G.B., Order S.E., Haulk T., Herpst J., Ettinger D.S., Fishman E.K., et al. Variable low dose rate irradiation (131I-anti-CEA) and integrated low dose chemotherapy in the treatment of nonresectable primary intrahepatic cholangiocarcinoma. Int J Radiat Oncol Biol Phys 21 (1991) 1601-1605